Literature DB >> 28238149

The occurrence of atrial fibrillation in dialysis patients and its association with left atrium volume before and after dialysis.

Beata Franczyk1, Anna Gluba-Brzózka2, Piotr Bartnicki1, Jacek Rysz1.   

Abstract

PURPOSE: Atrial fibrillation is a serious problem, especially in patients on dialysis. The prevalence of AF in this group of patients is higher than in general population and associated with increased mortality. The aim of this study was to assess the risk of the occurrence of atrial fibrillation related to intradialysis hypotension and left atrium volume enlargement associated with dialysis. The influence of dialysis session on: E/E', V LA, E/A, E', V RA and the width of inferior vena cava of RV was analyzed.
METHODS: This study included 40 patients on hemodialysis. Echocardiographic examination was performed to assess heart condition and function, the presence of LVH and systolic and diastolic function disturbances, LV mass, LA size, LAV, RAV, E/A, E', E/E, ejection fraction in all patients before and after dialysis. Moreover, all patients had ECG Holter continuously recording heart's rhythm before and after dialysis to assess the occurrence of atrial fibrillation related to dialysis session.
RESULTS: The analysis of differences in echocardiographic parameters before and after dialysis demonstrated significantly greater left atrium volume, right atrium volume, width of inferior vena cava and e' parameter before dialysis in comparison with post-dialysis state. Significantly higher incidence of AF after dialysis was seen. Volume of left atrium exceeding 32 mm (cutoff value) was observed significantly more often in patients before dialysis. No association was observed between left ventricle mass and left atrium volume.
CONCLUSIONS: The dialysis procedure may be a trigger for atrial fibrillation and thus AF preventive measures should be introduced in dialysis patients.

Entities:  

Keywords:  Atrial fibrillation; Dialysis; ECG Holter; Echocardiography; Left atrium volume; Left ventricle mass

Mesh:

Year:  2017        PMID: 28238149     DOI: 10.1007/s11255-017-1506-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  37 in total

1.  Evaluation of the Left Atrial Performance Using Acoustic Quantification.

Authors:  Christodoulos Stefanadis; John Dernellis; Pavlos Toutouzas
Journal:  Echocardiography       Date:  1999-01       Impact factor: 1.724

2.  Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients.

Authors:  F Fabbian; C Catalano; D Lambertini; G Tarroni; V Bordin; R Squerzanti; P Gilli; D Di Landro; R Cavagna
Journal:  Clin Nephrol       Date:  2000-09       Impact factor: 0.975

3.  The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk.

Authors:  Pamela S Douglas
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

4.  Effect of preload reduction by hemodialysis on conventional and novel echocardiographic parameters of left ventricular structure and function.

Authors:  Tomas Palecek; Lenka Skalicka; Jana Lachmanova; Vladimir Tesar; Ales Linhart
Journal:  Echocardiography       Date:  2008-02       Impact factor: 1.724

5.  The clinical course of left ventricular hypertrophy in dialysis patients.

Authors:  P S Parfrey; J D Harnett; S M Griffiths; R Taylor; J Hand; A King; P E Barre
Journal:  Nephron       Date:  1990       Impact factor: 2.847

6.  The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients.

Authors:  M S Buiten; M K de Bie; J I Rotmans; B A Gabreëls; W van Dorp; R Wolterbeek; S A Trines; M J Schalij; J W Jukema; T J Rabelink; L van Erven
Journal:  Heart       Date:  2014-03-26       Impact factor: 5.994

7.  Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.

Authors:  Simonetta Genovesi; Antonio Vincenti; Emanuela Rossi; Daniela Pogliani; Irene Acquistapace; Andrea Stella; Maria Grazia Valsecchi
Journal:  Am J Kidney Dis       Date:  2008-02       Impact factor: 8.860

8.  Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis.

Authors:  Maria Angela Losi; Bruno Memoli; Carla Contaldi; Giovanni Barbati; Marco Del Prete; Sandro Betocchi; Massimo Cavallaro; Gerardo Carpinella; Angelica Fundaliotis; Lucia-S Parrella; Valentina Parisi; Bruna Guida; Massimo Chiariello
Journal:  Nephrol Dial Transplant       Date:  2010-01-14       Impact factor: 5.992

9.  Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography.

Authors:  Teresa S M Tsang; Marion E Barnes; Bernard J Gersh; Yasuhiko Takemoto; A Gabriela Rosales; Kent R Bailey; James B Seward
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

10.  Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.

Authors:  Tomoko Tani; Kazuaki Tanabe; Miwa Ono; Kazuto Yamaguchi; Midori Okada; Toshiaki Sumida; Toshiko Konda; Yoko Fujii; Junichi Kawai; Toshikazu Yagi; Masatake Sato; Motoaki Ibuki; Minako Katayama; Koichi Tamita; Kenji Yamabe; Atsushi Yamamuro; Kunihiko Nagai; Kenichi Shiratori; Shigefumi Morioka
Journal:  J Am Soc Echocardiogr       Date:  2004-06       Impact factor: 5.251

View more
  2 in total

1.  Prevalence and associated factors of undiagnosed atrial fibrillation among end-stage renal disease patients on maintenance haemodialysis: a cross-sectional study.

Authors:  Izzat AlAwwa; Reham Al-Hindi; Nadeen Alfraihat; Ahmad Obeid; Sarah Ibrahim; Shatha Jallad; Ahmad Al-Awwa; Akram Saleh
Journal:  BMC Cardiovasc Disord       Date:  2020-04-21       Impact factor: 2.298

2.  Ultrafiltration rate and incident atrial fibrillation among older individuals initiating hemodialysis.

Authors:  Jennifer E Flythe; Sai Liu; Maria E Montez-Rath; Wolfgang C Winkelmayer; Tara I Chang
Journal:  Nephrol Dial Transplant       Date:  2021-11-09       Impact factor: 7.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.